Incyte (INCY) Gross Profit (2010 - 2026)
Incyte (INCY) reported Gross Profit of $1.2 billion for Q1 2026, up 19.23% on a YoY basis from $979.7 million in Q1 2025, and down 15.7% quarter-over-quarter from $1.4 billion in Q4 2025.
Incyte (INCY) Gross Profit (2010 - 2026) Analysis & Trends
Incyte has reported Gross Profit for 17 years, with the latest figure at $1.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 19.23% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $5.0 billion (up 21.24% YoY), and the FY2025 full-year result was $4.8 billion, up 21.38% from the prior year.
- Gross Profit for Q1 2026 stood at $1.2 billion, down from $1.4 billion in the prior quarter.
- The five-year high for Gross Profit was $1.4 billion in Q4 2025, with the low at $690.6 million in Q1 2022.
- Historically, Gross Profit has averaged $970.3 million across 5 years, with a median of $943.6 million in 2023.
- The largest YoY upside for Gross Profit was 28.92% in 2022 against a maximum downside of 0.57% in 2022.
- Incyte's Gross Profit stood at $867.5 million in 2022, then increased by 8.77% to $943.6 million in 2023, then gained by 15.54% to $1.1 billion in 2024, then climbed by 27.1% to $1.4 billion in 2025, then slipped by 15.7% to $1.2 billion in 2026.
- The last three Gross Profit figures came in at $1.2 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Bn |
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 1.27 Bn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 979.71 Mn |
| Mar 31, 2025 | 979.71 Mn |
| Dec 31, 2024 | 1.09 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 967.13 Mn |
| Jun 30, 2024 | 967.13 Mn |
| Mar 31, 2024 | 819.93 Mn |
| Mar 31, 2024 | 819.93 Mn |
| Dec 31, 2023 | 943.59 Mn |
| Dec 31, 2023 | 943.59 Mn |